Evaluation of empirical antibiotherapy for acute community-acquired pneumonia prescribed in emergency departments

Medecine et Maladies Infectieuses

Volumn 42, Issue 1, 2012, Pages 5-9

  Fraisse, T ^a   Fayad, G ^b   Jardy, C ^b   Sotto, A ^c  

^a Court séjour gériatrique ^*  (France)

^b Centre Hospitalier de Bagnols sur Cèze   (France)

^c Service de Maladies Infectieuses et Tropicales   (France)

Author keywords

Antibiotic; Community acquired pneumonia; Evaluation

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; C REACTIVE PROTEIN; CEFTRIAXONE; CEPHALOSPORIN; LEVOFLOXACIN; METRONIDAZOLE; OFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SPIRAMYCIN; TELITHROMYCIN;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BLOOD CULTURE; BLOOD SAMPLING; CLINICAL ASSESSMENT; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED STUDY; COUGHING; DISEASE SEVERITY; DRUG COST; DRUG RESPONSE; EMERGENCY TREATMENT; EMERGENCY WARD; FEMALE; FEVER; HOSPITALIZATION; HUMAN; LEGIONELLA; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRESCRIPTION; RETROSPECTIVE STUDY; SYMPTOM; THORAX RADIOGRAPHY; UNSPECIFIED SIDE EFFECT;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; COMMUNITY-ACQUIRED INFECTIONS; DIAGNOSTIC TESTS, ROUTINE; DISEASE MANAGEMENT; DRUG UTILIZATION; EMERGENCY SERVICE, HOSPITAL; FEMALE; GUIDELINE ADHERENCE; HUMANS; INAPPROPRIATE PRESCRIBING; MALE; MIDDLE AGED; PNEUMONIA, BACTERIAL; PRACTICE GUIDELINES AS TOPIC; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84855822066     PISSN: 0399077X     EISSN: 17696690     Source Type: Journal    
DOI: 10.1016/j.medmal.2011.10.019     Document Type: Article

References (15)

1. e conférence de consensus en thérapeutique anti-infectieuse. Prise en charge des infections des voies respiratoires basses de l'adulte immunocompétent. Med Mal Infect 2006, 36:235-244. Société de pathologie infectieuse de langue française.
2. AFSSAPS. Antibiothérapie par voie générale dans les infections respiratoires basses de l'adulte, pneumonie aiguë communautaire, exacerbation de broncho-pneumopathie chronique obstructive. Publication online sur, juillet 2010. http://www.afssaps.sante.fr/.
3. Frei C.R., Attridge R.T., Mortensen E.M., Restrepo M.I., Yu Y., Oramasionwu C.U., et al. Guideline-concordant antibiotic use and survival among patients with community-acquired pneumonia admitted to the intensive care unit. Clin Ther 2010, 32:293-299.
4. Bodí M., Rodríguez A., Solé-Violán J., Gilavert M.C., Garnacho J., Blanquer J., et al. Community-acquired pneumonia intensive care units (CAPUCI) study investigators. Antibiotic prescription for community-acquired pneumonia in the intensive care unit: impact of adherence to Infectious diseases society of america guidelines on survival. Clin Infect Dis 2005, 41:1709-1716.
5. Dean N.C., Bateman K.A., Donnelly S.M., Silver M.P., Snow G.L., Hale D. Improved clinical outcomes with utilization of a community-acquired pneumonia guideline. Chest 2006, 130:794-799.
6. Minchella A., Lechiche C., Poujol H., Molinari N., Sotto A. Méthode d'évaluation des pratiques professionnelles (EPP) au cours de l'antibiothérapie des pneumopathies aiguës communautaires. Med Mal Infect 2010, 40:100-105.
7. Labarère J., Fourny M., Pavese P., Bedouch P., Brambilla C., François P. Concordance des recommandations de prise en charge des pneumonies aiguës communautaires. étude rétrospective sur un échantillon de 101 patients hospitalisés. Rev Mal Respir 2003, 20:841-843.
8. Vilani P., Barlesi F., Paraponaris A., Escarguel B., Torre J.P., Gregoire V., et al. Enquête sur la prise en charge thérapeutique des malades hospitalisés pour infection respiratoire basse communautaire. Presse Med 2003, 32:1792-1796.
9. Navas D., Caillon J., Potel G. Bon usage des antibiotiques à l'hôpital. évaluation des pratiques professionnelles de prise en charge des pneumonies communautaires. Presse Med 2005, 34:1687-1695.
10. Charlson M.E., Pompei P., Ales K.L., MacKenzie C.R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987, 40:373-383.
11. Fine M.J., Auble T.E., Yealy D.M., Hanusa B.H., Weissfeld L.A., Singer D.E., et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997, 336:243-250.
12. Halm E.A., Horowitz C., Silver A., Fein A., Dlugacz Y.D., Hirsch B., et al. Limited impact of a multicenter intervention to improve the quality and efficiency of pneumonia care. Chest 2004, 126:100-107.
13. Metlay J., Schulz R., Li Y.-H., Singer D., Marrie T., Coley C., et al. Influence of age on symptoms at presentation in patients with community-acquired pneumonia. Arch Intern Med 1997, 157:1453-1459.
14. Metersky M.L., Ma A., Bratzler D.W., Houck P.M. Predicting bacteriemia in patients with community-acquired pneumonia. Am J Respir Crit Care Med 2004, 169:342-347.
15. Mol P.G., Gans R.O., Panday P.V., Degener J.E., Laseur M., Haaijer-Ruskamp F.M. Reliability of assessment of adherence to an antimicrobial treatment guideline. J Hosp Infect 2005, 60:321-328.